Publications by authors named "C R Revankar"

Article Synopsis
  • On June 8, 2022, the WHO launched a strategic framework aimed at addressing skin-related neglected tropical diseases (skin NTDs), which include at least 9 different diseases affecting the skin.
  • The framework shifts away from treating these diseases individually and encourages finding commonalities among them to enhance health impacts.
  • It seeks to promote integrated treatment strategies, contributing to broader health goals like Universal Health Coverage and improving skin health for everyone.
View Article and Find Full Text PDF

CRISPR/Cas9 is increasingly being used as a tool to prosecute functional genomic screens. However, it is not yet possible to apply the approach at scale across a full breadth of cell types and endpoints. In order to address this, we developed a novel and robust workflow for array-based lentiviral CRISPR/Cas9 screening.

View Article and Find Full Text PDF

Estrogen exerts extensive and diverse effects throughout the body of women. In addition to the classical nuclear estrogen receptors (ERα and ERβ), the G protein-coupled estrogen receptor GPER is an important mediator of estrogen action. Existing ER-targeted therapeutic agents act as GPER agonists.

View Article and Find Full Text PDF

Cellular assay development for the endothelial differentiation gene (EDG) family of G-protein-coupled receptors (GPCRs) and related lysophospholipid (LP) receptors is complicated by endogenous receptor expression and divergent receptor signaling. Endogenously expressed LP receptors exist in most tissue culture cell lines. These LP receptors, along with other endogenously expressed GPCRs, contribute to off-target signaling that can complicate interpretation of second-messenger-based cellular assay results.

View Article and Find Full Text PDF